GoodRx Holdings' ROCE trend is concerning. Despite reinvestment in its business, shrinking returns and a significant stock price drop hint at a lack of multi-bagger potential.
RECAP US Stocks Retreat After Rallying in 2023 US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated. A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The$纳斯达克综合指数(.IXIC.US)$fell 1.6% to close at 14,765.94, its biggest daily decline since October. The$标普500指数(.SPX.US)$slipped 0...
15225861173035898:
bro you n know big heart faith and years of pain only way is up from the bottom love peace harmony goal to buy 3rd world country to save and feed
Concern arises over GoodRx Holdings' high P/S ratio as future revenue projections seem insufficient to maintain positive evaluation. Unless significant revenue improvements occur, high P/S values likely unsustainable.
$GoodRx(GDRX.US)$fell Tuesday after raising 13% last week. The drop followed$西维斯健康(CVS.US)$investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
Stock is near 52 week low. large block purchases are being made on this dip still might have room to be lower. going to take position on the stock due to revenue and brand name. if there is any kind of recession in the near future the stock will be back up to its high due to individuals looking for the best options to pay for their prescriptions. good luck investing 😸
GoodRx's diminishing returns, despite reinvestment, is disheartening. Its sharp stock price drop could indicate investor anticipation of worsening company fundamentals, suggesting other investment options may be more promising.
Pre-Market Stock Movers Gapping up $Adobe(ADBE.US)$ (The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.) $雪佛龙(CVX.US)$ (Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.) $迪士尼(DIS.US)$ (T...
GoodRx股票讨论区
📊⚡️📊
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $纳斯达克综合指数(.IXIC.US)$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $标普500指数(.SPX.US)$ slipped 0...
good luck investing 😸
值得注意的是上市当年营业利润的2.76亿巨亏主要来自管理费用暴增至4.6亿，从第二年降回1.55亿可以知道上市为管理层个人带来了多少利润，尽管公司仍在巨亏。
2023上半年营收下滑了5.4%，靠缩减营业费用营业利润提升到了0.3亿，靠所得税返还净利润达到了0.55亿。
目前市盈率TTM278，综合来看没有投资价值。
Gapping up
$Adobe(ADBE.US)$
(The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.)
$雪佛龙(CVX.US)$
(Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.)
$迪士尼(DIS.US)$
(T...
暂无评论